Search Results

You are looking at 1 - 10 of 45 items for :

Clear All
Full access

Diego de Alcantara Borba, Eduardo da Silva Alves, João Paulo Pereira Rosa, Lucas Alves Facundo, Carlos Magno Amaral Costa, Aldo Coelho Silva, Fernanda Veruska Narciso, Andressa Silva and Marco Túlio de Mello

It is possible to notice that physical exercise plays an important role in endocrinal systems linked to muscle function. The muscle response to exercise results in acute hormone changes such as an increase in growth hormone (GH) and also perhaps on insulin-like growth factor-1 (IGF-1) levels. 1 The

Restricted access

Manu V. Chakravarthy, Frank W. Booth and Espen E. Spangenburg

Approximately 50% of humans older than 85 years have physical frailty due to weak skeletal muscles. This indicates a need for determining mechanisms to combat this problem. A critical cellular factor for postnatal muscle growth is a population of myogenic precursor cells called satellite cells. Given the complex process of sarcopenia, it has been postulated that, at some point in this process, a limited satellite cell proliferation potential could become rate-limiting to the regrowth of old muscles. It is conceivable that if satellite cell proliferative capacity can be maintained or enhanced with advanced age, sarcopenia could potentially be delayed or prevented. Therefore, the purposes of this paper are to describe whether IGF-I can prevent muscular atrophy induced by repeated cycles of hindlimb immobilization, increase the in vitro proliferation in satellite cells from these muscles and, if so, the molecular mechanisms by which IGF-1 mediates this increased proliferation. Our results provide evidence that IGFI can enhance aged muscle regrowth possibly through increased satellite cell proliferation. The results also suggest that IGF-I enhances satellite cell proliferation by decreasing the cell cycle inhibitor, p27Kip1, through the PI3’-K/Akt pathway. These data provide molecular evidence for IGF-I’s rescue effect upon aging-associated skeletal muscle atrophy.

Restricted access

Bjoern Geesmann, Jenna C. Gibbs, Joachim Mester and Karsten Koehler

Ultraendurance athletes often accumulate an energy deficit when engaging in ultraendurance exercise, and on completion of the exercise, they exhibit endocrine changes that are reminiscent of starvation. However, it remains unclear whether these endocrine changes are a result of the exercise per se or secondary to the energy deficit and, more important, whether these changes can be attenuated by increased dietary intake. The goal of the study was to assess the relationship between changes in key metabolic hormones after ultraendurance exercise and measures of energy balance. Metabolic hormones, as well as energy intake and expenditure, were assessed in 14 well-trained male cyclists who completed a 1230-km ultraendurance cycling event. After completion of the event, serum testosterone (–67% ± 18%), insulin-like growth factor-1 (IGF-1) (–45% ± 8%), and leptin (–79% ± 9%) were significantly suppressed (P < .001) and remained suppressed after a 12-h recovery period (P < .001). Changes in IGF-1 were positively correlated with energy balance over the course of the event (r = .65, P = .037), which ranged from an 11,859-kcal deficit to a 3593-kcal surplus. The marked suppression of testosterone, IGF-1, and leptin after ultraendurance exercise is comparable to changes occurring during acute starvation. The suppression of IGF-1, but not that of other metabolic hormones, was strongly associated with the magnitude of the energy deficit, indicating that athletes who attained a greater energy deficit exhibited a more pronounced drop in IGF-1. Future studies are needed to determine whether increased dietary intake can attenuate the endocrine response to ultraendurance exercise.

Restricted access

Whitney R.D. Duff, Philip D. Chilibeck, Julianne J. Rooke, Mojtaba Kaviani, Joel R. Krentz and Deborah M. Haines

Bovine colostrum is the first milk secreted by cows after parturition and has high levels of protein, immunoglobulins, and various growth factors. We determined the effects of 8 weeks of bovine colostrum supplementation versus whey protein during resistance training in older adults. Males (N = 15, 59.1 ± 5.4 y) and females (N = 25, 59.0 ± 6.7 y) randomly received (double-blind) 60g/d of colostrum or whey protein complex (containing 38g protein) while participating in a resistance training program (12 exercises, 3 sets of 8–12 reps, 3 days/week). Strength (bench press and leg press 1-RM), body composition (by dual energy x-ray absorptiometry), muscle thickness of the biceps and quadriceps (by ultrasound), cognitive function (by questionnaire), plasma insulin-like growth factor-1 (IGF-1) and C-reactive protein (CRP, as a marker of inflammation), and urinary N-telopeptides (Ntx, a marker of bone resorption) were determined before and after the intervention. Participants on colostrum increased leg press strength (24 ± 29 kg; p < .01) to a greater extent than participants on whey protein (8 ± 16 kg) and had a greater reduction in Ntx compared with participants on whey protein (–15 ± 40% vs. 10 ± 42%; p < .05). Bench press strength, muscle thickness, lean tissue mass, bone mineral content, and cognitive scores increased over time (p < .05) with no difference between groups. There were no changes in IGF-1 or CRP. Colostrum supplementation during resistance training was beneficial for increasing leg press strength and reducing bone resorption in older adults. Both colostrum and whey protein groups improved upper body strength, muscle thickness, lean tissue mass, and cognitive function.

Restricted access

James A. Betts, Keith A. Stokes, Rebecca J. Toone and Clyde Williams

Endocrine responses to repeated exercise have barely been investigated, and no data are available regarding the mediating influence of nutrition. On 3 occasions, participants ran for 90 min at 70% VO2max (R1) before a second exhaustive treadmill run at the same intensity (R2; 91.6 ± 17.9 min). During the intervening 4-hr recovery, participants ingested either 0.8 g sucrose · kg−1 · hr−1 with 0.3 g · kg−1 · hr−1 whey-protein isolate (CHO-PRO), 0.8 g sucrose · kg−1 · hr−1 (CHO), or 1.1 g sucrose · kg−1 · hr−1 (CHO-CHO). The latter 2 solutions therefore matched the former for carbohydrate or for available energy, respectively. Serum growth-hormone concentrations increased from 2 ± 1 μg/L to 17 ± 8 μg/L during R1 considered across all treatments (M ± SD; p ≤ .01). Concentrations were similar immediately after R2 irrespective of whether CHO or CHO-CHO was ingested (19 ± 4 μg/L and 19 ± 5 μg/L, respectively), whereas ingestion of CHO-PRO produced an augmented response (31 ± 4 μg/L; p ≤ .05). Growth-hormone-binding protein concentrations were unaffected by R1 but increased similarly across all treatments during R2 (from 414 ± 202 pmol/L to 577 ± 167 pmol/L; p ≤ .01), as was the case for plasma total testosterone (from 9.3 ± 3.3 nmol/L to 14.7 ± 4.6 nmol/L; p ≤ .01). There was an overall treatment effect for serum cortisol (p ≤ .05), with no specific differences at any given time point but lower concentrations immediately after R2 with CHO-PRO (608 ± 133 nmol/L) than with CHO (796 ± 278 nmol/L) or CHO-CHO (838 ± 134 nmol/L). Ingesting carbohydrate with added whey-protein isolate during short-term recovery from 90 min of treadmill running increases the growth-hormone response to a second exhaustive exercise bout of similar duration.

Restricted access

Joshua N. Farr, Deepika R. Laddu and Scott B. Going

Although primarily considered a disorder of the elderly, emerging evidence suggests the antecedents of osteoporosis are established during childhood and adolescence. A complex interplay of genetic, environmental, hormonal and behavioral factors determines skeletal development, and a greater effort is needed to identify the most critical factors that establish peak bone strength. Indeed, knowledge of modifiable factors that determine skeletal development may permit optimization of skeletal health during growth and could potentially offset reductions in bone strength with aging. The peripubertal years represent a unique period when the skeleton is particularly responsive to loading exercises, and there is now overwhelming evidence that exercise can optimize skeletal development. While this is not controversial, the most effective exercise prescription and how much investment in this prescription is needed to significantly impact bone health continues to be debated. Despite considerable progress, these issues are not easy to address, and important questions remain unresolved. This review focuses on the key determinants of skeletal development, whether exercise during childhood and adolescence should be advocated as a safe and effective strategy for optimizing peak bone strength, and whether investment in exercise early in life protects against the development of osteoporosis and fractures later in life.

Restricted access

Michael P. Corcoran, Miriam E. Nelson, Jennifer M. Sacheck, Kieran F. Reid, Dylan Kirn, Roger A. Fielding, Kenneth K.H. Chui and Sara C. Folta

, Teixeira, & Lazaretti-Castro, 2009 ; Tieland, Dirks, et al., 2012 ; Tieland, van de Rest, et al., 2012 ). Stimulation of anabolic factors such as insulin-like growth factor-1 (IGF-1) has been noted with postexercise protein and vitamin D supplementation, and therefore may aid in mitigating any age

Restricted access

Geoffrey Goldspink and Shi Yu Yang

For some time, it has been appreciated that muscle mass is regulated locally as well as systemically. We have cloned the cDNA of two isoforms of IGF-1, which are derived from the IGF-1 gene by alternate splicing. The expression of one of these was only detectable after mechanical stimulation. For this reason, this has been called mechano growth factor (MGF). The MGF is not glycosylated, is smaller, and has a shorter half-life in the unbound state than the systemic liver type IGF-1. As the result of a reading frame shift the MGF peptide also has a different C terminal sequence and thus has different binding protein/receptor affinities. Another splice variant (muscle L.IGF-I) is expressed in muscle during rest but is also upregulated by exercise. The latter is similar to the systemic liver type IGF-1. The evidence suggests that MGF has a high potency for inducing local protein synthesis and preventing apoptosis and therefore has an important role in local tissue repair and remodeling. Our physiological experiments show that stretch and particularly stretch combined with electrical stimulation, rather than stimulation alone are important in inducing MGF expression. The mechanotransduction mechanism is believed to involve the muscle cytoskeleton. During aging, the production of growth hormone and IGF-1 by the liver declines markedly. The discovery of MGF and muscle IGF-1 provides a link between physical activity and gene expression. This underlines the need for the elderly to remain active as the locally produced growth factors supplement the circulating IGF-1 levels.

Restricted access

M.R. Orenstein and C.M. Friedenreich


To review systematically all publications of the effects of exercise on endogenous insulin-like growth factor (IGF) to clarify the nature of this association.


We reviewed 115 research studies in humans by subgroup of population (age; sex; athletic training status), physical activity exposure (resistance vs. aerobic activity; duration of activity) and study design.


Fifty percent of studies reviewed found no difference in total circulating IGF-1 as a result of exercise; 37% showed an increase, and 13% observed decreases in IGF-1 levels with exercise. Age influenced the effects of exercise on IGF levels. Exercise appeared to decrease IGF-1 levels in children, but to increase levels in young adults. Similar results were found for IGFBP-3.


It is not yet possible to determine if exercise affects IGF levels. Important methodologic differences among studies, as well as concerns about study quality, limit the ability to draw firm conclusions.

Restricted access

Izabella A. Ludwa, Bareket Falk, Matthew Yao, Lauren Corbett and Panagiota Klentrou

This pilot study compared bone speed of sound (SOS), bone turnover and insulin-like growth factor 1 (IGF-1) between 20 Caucasian, postmenarcheal, adolescent synchronized swimmers (SS) and 20 aged- and maturity-matched nonswimmers (NS). Daily dietary intake and physical activity levels were also assessed. Bone SOS was measured by quantitative ultrasound. Blood samples were analyzed for osteocalcin, cross-linked N-teleopeptide of type I collagen (NTx), IGF-I and 25-OH vitamin D. Although no differences in bone SOS or turnover markers were observed between groups, the lower IGF-1 and vitamin D intake found in synchronized swimmers, in combination with their higher strenuous activity levels, should be further explored.